134 related articles for article (PubMed ID: 10993660)
1. Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells.
Sharrard RM; Maitland NJ
Br J Cancer; 2000 Oct; 83(8):1102-9. PubMed ID: 10993660
[TBL] [Abstract][Full Text] [Related]
2. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.
Morimoto AM; Berson AE; Fujii GH; Teng DH; Tavtigian SV; Bookstein R; Steck PA; Bolen JB
Oncogene; 1999 Feb; 18(6):1261-6. PubMed ID: 10022807
[TBL] [Abstract][Full Text] [Related]
4. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
5. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.
Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
Fujii GH; Morimoto AM; Berson AE; Bolen JB
Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the human PTEN/MMAC1/TEP1 gene.
Sharrard RM; Maitland NJ
Biochim Biophys Acta; 2000 Dec; 1494(3):282-5. PubMed ID: 11121587
[TBL] [Abstract][Full Text] [Related]
9. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
11. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
[TBL] [Abstract][Full Text] [Related]
12. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Tsao H; Zhang X; Fowlkes K; Haluska FG
Cancer Res; 2000 Apr; 60(7):1800-4. PubMed ID: 10766161
[TBL] [Abstract][Full Text] [Related]
13. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
[TBL] [Abstract][Full Text] [Related]
15. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
Yuan XJ; Whang YE
Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475
[TBL] [Abstract][Full Text] [Related]
16. PTEN/MMAC1 mutations in hepatocellular carcinomas.
Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
[TBL] [Abstract][Full Text] [Related]
17. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness.
Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E
J Cell Biol; 2001 Dec; 155(7):1129-35. PubMed ID: 11756467
[TBL] [Abstract][Full Text] [Related]
18. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
[TBL] [Abstract][Full Text] [Related]
19. PTEN/MMAC1 expression in esophageal squamous cell carcinomas.
Ding Y; Shimada Y; Kano M; Itami A; Kawabe A; Maeda M; Li Z; Hong T; Sato F; Kaganoi J; Imamura M
Int J Oncol; 2000 Oct; 17(4):695-9. PubMed ID: 10995879
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
